Effect of FODMAP Diet on Pain, Quality of Life, and Sexual Function in Women With Pelvic Endometriosis and Gastrointestinal Symptoms
FODMAPendo
1 other identifier
interventional
150
1 country
1
Brief Summary
The main objective of the study is to assess whether a dietary regimen based on the principles of the FODMAP diet, compared with the current treatment programme which does not include specific dietary recommendations, can improve pain symptoms in patients with symptomatic endometriosis and intestinal symptoms (i.e. bloating, nausea, constipation, diarrhoea and vomiting) attributable to irritable bowel syndrome, compared with a control group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 10, 2024
CompletedFirst Posted
Study publicly available on registry
May 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
May 15, 2026
April 1, 2026
2.7 years
May 10, 2024
May 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change of pain related syntomps in patients with bowel symptoms
The primary objective of the study is to evaluate whether a dietary regimen based on the principles of the FODMAP diet versus the current treatment program, which does not include specific dietary indications, can change algic symptoms in patients with symptomatic endometriosis and the presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, compared with a control group. The outcome will be measured trough Numerical Rating Scale (NRS) on dismenorrea, dyspareunia, non menstrual pelvic pain and dyschezia.
6 months
Secondary Outcomes (1)
Gastrointestinal syntomps, patient satisfaction, health-related quality of life, psychological conditions, patient's overall condition and anthropometric parameters
6 months
Study Arms (2)
FODMAP diet group
EXPERIMENTALPatients randomized to the treatment arm were proposed to follow a FODMAP diet throughout the study period
Usual diet group
NO INTERVENTIONInterventions
Diet low in oligosaccharides, disaccharides, monosaccharides and fermentable polyols
Eligibility Criteria
You may qualify if:
- Age between 18 and 45 years
- BMI between 18.5 and 24.9,
- Surgical, clinical or instrumental diagnosis of endometriosis
- Presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, on estro-progestin or progestin treatment or in the absence of hormonal treatment
You may not qualify if:
- Associated conditions that may cause pelvic pain independent of the presence of endometriosis (e.g., pelvic varices and salpingitis outcomes)
- chronic inflammatory bowel disease (Crohn's disease or ulcerative rectocolitis).
- patients with obstructive uropathy, subocclusive intestinal stenosis
- complex adnexal masses or typical endometriomas greater than 5 cm in diameter.
- women who are obese (BMI ≥ 30) or underweight (BMI \< 18)
- women on vegetarian-vegan dietary regimens,
- women with metabolic diseases that require specific dietary indications such as in the case of diabetes and celiac disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Milan, 20122, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2024
First Posted
May 15, 2026
Study Start
March 1, 2024
Primary Completion (Estimated)
November 15, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
May 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share